Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.69
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year […]
More Stories
West Oak Capital LLC Acquires 3,109 Shares of iShares Core S&P 500 ETF (NYSEARCA:IVV)
West Oak Capital LLC raised its holdings in iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 287.6% in...
Progyny (NASDAQ:PGNY) Shares Up 3.1% – Should You Buy?
Progyny, Inc. (NASDAQ:PGNY – Get Free Report)’s stock price shot up 3.1% on Wednesday . The stock traded as high...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6.7% – Here’s What Happened
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) traded down 6.7% on Wednesday . The company traded...
PayPal (NASDAQ:PYPL) Shares Down 0.3% – Here’s Why
PayPal Holdings, Inc. (NASDAQ:PYPL – Get Free Report)’s stock price traded down 0.3% during mid-day trading on Wednesday . The...
Invesco QQQ (NASDAQ:QQQ) Stock Price Up 0% – Here’s Why
Invesco QQQ (NASDAQ:QQQ – Get Free Report)’s share price shot up 0% during mid-day trading on Wednesday . The stock...
Ecor1 Capital, Llc Purchases 21,021 Shares of Zymeworks Inc. (NYSE:ZYME) Stock
Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 21,021 shares of Zymeworks stock in a transaction...